Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹590 Cr₹611 Cr₹1,695 Cr₹358 Cr₹93 Cr

What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹590 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹590 Cr
Mar2024₹611 Cr
Mar2023₹1,695 Cr
Mar2022₹358 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹590 Cr
-3.39
Mar2024 ₹611 Cr
-63.97
Mar2023 ₹1,695 Cr
373.19
Mar2022 ₹358 Cr
284.26
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,270.8 Cr -5.1% -13.8% -21.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-5.1%

-13.8%

-21.1%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses